NVAMD Satellite Study

计划入组 66 人 · 首次发布于 2014 年 9 月 29 日

ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)

计划入组 64 人 · 首次发布于 2017 年 12 月 5 日

Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD

计划入组 9 人 · 首次发布于 2015 年 11 月 6 日

Merck Initiates Pivotal Phase 2b/3 Trial for Novel Bispecific Antibody MK-8748 in Wet Age-Related Macular Degeneration

MSD Completes $3 Billion Acquisition of EyeBio, Gaining Novel Retinal Disease Candidate Restoret

Real-World Study Shows Faricimab Improves Outcomes in nAMD Patients